Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The Impact of Serum Leptin, Leptin Receptor and Insulin on Maternal Obesity


Affiliations
1 Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq
2 College of Medicine, Mustansiriyah University, Baghdad, Iraq
3 College of Biotechnology, Al-Nahrain University, Baghdad, Iraq
     

   Subscribe/Renew Journal


The prevalence of overweight and obesity is rising worldwide, particularly, among women of reproductive age. Obesity during pregnancy can result in adverse outcomes for both mothers and fetuses. The current study was carried out to investigate whether the leptin (LEP), leptin receptor (LEPR) and insulin have a role in obesity development among Iraqi pregnant women. A case-control study included 90 pregnant women recruited at term for a scheduled cesarean delivery and classified equally according to body mass index (BMI) into three groups; control, overweight, and obese. Insulin, LEP, and LEPR were measured by enzyme-linked immunosorbent assay (ELISA). Obese group showed a significant increase in serum LEP (P<0.001), LEPR (p<0.05) and fasting insulin (P<0.05) concentrations compared with control group. Meanwhile, overweight females showed a significant (P<0.05) increase only in serum LEP and LEP/LEPR ratio (P<0.001,) compared to control group. Furthermore, maternal BMI was positively associated with, LEPR (adjusted r = 0.276, β: 0.104, P<0.01), LEP (adjusted r = 0.471, β: 0.256, P<0.001), and insulin (adjusted r = 0.439, β: 0.363, P<0.001) among entire data set. Similarly, BMI was positively associated with LEP (adjusted r = 0.297, β: 0.161, P<0.05), LEPR (adjusted r=0.444, β: 0.133, P<0.001) and insulin (adjusted r = 0.432, β: 0.266, P<0.001) among overweight/obese females. In Conclusion both of LEP and insulin are the strongest predictor for maternal BMI after age adjustment, while among overweight/obese females, LEPR has greatest impact on maternal obesity and insulin comes in second place.

Keywords

Maternal Obesity, Body Mass Index, Leptin, Leptin Receptor, Insulin, Lipid Profile, Insulin Resistance.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Desai M, Beall M, and Ross MG. Developmental Origins of Obesity: Programmed Adipogenesis. Curr Diab Rep. 2013, 13(1): 27–33.

  • Martens DS. et al. Maternal pre-pregnancy body mass index and newborn telomere length. BMC Medicine. 2016, 14:148.

  • Mann J, et al. Pre-pregnancy body mass index, weight change during pregnancy, and risk of intellectual disability in children. BJOG. 2013, 120: 309–319.

  • Arora T, et al. The Role of Genetic, Dietary and Lifestyle Factors in Pediatric Metabolic Syndrome: A Review of the Literature from Prenatal to Adolescence,” Arab Journal of Nutrition and Exercise. 2017, 2(1): 1–22.

  • Haugen M, et al. Associations of pre-pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum weight retention: a prospective observational cohort study. BMC Pregnancy Childbirth. 2014, 14: 201.

  • Tanvig M, et al. Pregestational body mass index is related to neonatal abdominal circumference at birth-a Danish population-based study. BJOG 2013, 120:320–330.

  • World Health Organization (WHO) Obesity and overweight Fact sheet 2014. Available from: URL: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  • Nigro E, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014, 2014: 658913.

  • Chearskul S, et al. Obesity and appetite-related hormones. J Med Assoc Thai. 2012; 95(11):1472-9.

  • Mohan M. The Role of Leptin on Obesity: A Review. Research J. Pharm. and Tech. 2014; 7(12): 1501-1505.

  • Mohsen H, et al. Correlation of serum leptin levels with insulin resistance in Syrian obese patients with type 2 diabetes mellitus. Research J. Pharm. and Tech. 2013; 6(10): 1149-1151.

  • Rosická M, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. Physiol Res. 2003; 52(1): 61-6.

  • Myers M G, Greenwald-Yarnell M. Handbook of Biologically Active Peptides. Academic Press. 3013; 2

  • nd edition: pp. 1129–1134.

  • Fu, Z., Gilbert, E. R., & Liu, D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Current diabetes reviews, 2013; 9(1): 25-53.

  • Ye J. Mechanisms of insulin resistance in obesity. Frontiers of medicine. 2013: 7(1): 14-24.

  • Chao, A. M, et al. Stress, cortisol, and other appetite‐related hormones: Prospective prediction of 6‐month changes in food cravings and weight. Obesity. 2017; 25: 713-720.

  • Sinha R, Jastreboff AM. Stress as a common risk factor for obesity and addiction. Biol Psychiatry. 2013; 73: 827‐835.

  • World Health Organization (WHO) Obesity and overweight Fact sheet Reviewed February 2018. Available from: URL: http://www.who.int/mediacentre/factsheets/fs311/en/.

  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.

  • Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 (7): 412–9.

  • Ugwuja, E., et al. Overweight and Obesity, Lipid Profile and Atherogenic Indices among Civil Servants in Abakaliki, South Eastern Nigeria. Annals of Medical and Health Sciences Research. 2013; 3(1): 13–18.

  • Al-Shareefi AN, et al. Assessment of insulin resistant and the related cardio-metabolic factors in overweight-obese women presented with missed abortion, Baghdad, Iraq. Saudi J Obesity. 2015; 3:66-71.

  • Haddad N I. A., Nori E, and Hamza S A. Serum Visfatin and Chemerin Levels in Iraqi Diabetics and Obese Individuals. RJPBCS. 2017; 8(6): 356-64.

  • Turki K M, Alosami M H, Abdul-Qahar Z H. The Effect of Obesity on Serum Leptin and Lipid Profile. The Iraqi Postgraduate Medical Journal. 2009;1(1): 27-32.

  • Howard BV, Ruotolo G, and Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003; 32: 855–867.

  • Sheth, J., et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clinical Diabetes and Endocrinology. 2015; 1, 6.

  • Bays H E. et al. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology. 2013; 7(4): 304 – 383.

  • Bala, M., Meenakshi, K, M., & Gupta, A. Correlation of HbA1C Levels With Body Mass Index in Newly Diagnosed Polycystic Ovary Syndrome. EJIFCC. 2017; 28(3): 196-204.

  • Gayoso-Diz P, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocrine Disorders. 2013; 13(1): 1.

  • Ben Slamaa F, et al. Plasma levels of leptin and ghrelin and their correlationwith BMI, and circulating lipids and glucose in obeseTunisian women. Asian Biomedicine. 2015; 9 (2): 161-168.

  • Van Dielen F M. H., et al. Leptin and Soluble Leptin Receptor Levels in Obese and Weight-Losing Individuals, The Journal of Clinical Endocrinology & Metabolism. 2002; 87(4): 1708–1716.

  • Mohamed A K, Hassan A J. Assess the relationship between leptin levels with classes of obesity in adult of Babylon, Iraq. Mesopo. Environ. j. 2017Special Issue C :130-135.

  • Park HK, & Ahima RS. Physiology of Leptin: Energy Homeostasis, Neuroendocrine Function and Metabolism. Metabolism: Clinical and Experimental. 2015; 64: 24-34.

  • Crujeiras A B, et al. Casanueva, Leptin resistance in obesity: An epigenetic landscape, Life Sciences. 2015; 140: 57-63.

  • Riccioni G, et al. Interaction Connecting Leptin·Obesity-Insulin Dependent Diabetes Mellitus. European Journal Of Inflammation. 2004; 2(1): 17-20.

  • Herrick JE, Panza GS, & Gollie JM. Leptin, Leptin Soluble Receptor, and the Free Leptin Index following a Diet and Physical Activity Lifestyle Intervention in Obese Males and Females. Journal of Obesity. 2016; 2016: 8375828.

  • Hocking S, et al. Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots. Endocrine Reviews. 2013; 34(4):463–500.

  • Magni, P, et al. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile and macronutrient preference. Clinical Endocrinology. 2005; 62: 189-196.

  • Wasim M, et al. Role of Leptin Deficiency, Inefficiency, and Leptin Receptors in Obesity. Biochem Genet. 2016; 54(5): 565-72.

  • Mohamed AK and Hassan AJ. Assess the relationship between insulin fasting levels and healthy obesity in adults in the province of Babylon, Iraq. Iraqi National Journal of Chemistry. 2015; 15(4): 318-328.

  • Szczygielska A, et al. Blood lipids profile in obese or overweight patients. Ann Univ Mariae Curie Sklodowska Med. 2003; 58(2): 343-9.

  • Bakari AG, et al. Relationship between casual blood sugar and body mass index in a suburban northern Nigerian population: a short communication. Niger J Med. 2007; 16(1):77-8.

  • Singh Y., et al. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. Journal of clinical research in pediatric endocrinology. 2013; 5(4): 245-51.

  • Hossain I, et al. Fasting blood glucose level and its association with sex, body mass index and blood pressure: a cross sectional study on a Bangladeshi public university students. Int J Community Med Public Health. 2017; 4(8): 2663-2669.

  • Omran D M, et al. Relationship between Ghrelin and Leptin with Insulin Resistance in Obese Patients and Non-Obese Individuals. Research J. Pharm. and Tech. 2018; 11(1): 281-283.

  • Bakari A G, et al. Relationship between random blood sugar and body mass index in an African population. Int J Diabetes & Metabolism. 2006; 14: 144-145.

  • Goossens, GH. The role of adipose tissue dysfunction in the pathogenesis of obesity- related insulin resistance. Nat. Med. 2014; 20: 1427–1435.


Abstract Views: 307

PDF Views: 0




  • The Impact of Serum Leptin, Leptin Receptor and Insulin on Maternal Obesity

Abstract Views: 307  |  PDF Views: 0

Authors

Shahla O. Al-Ogaidi
Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq
Sura A. Abdulsattar
College of Medicine, Mustansiriyah University, Baghdad, Iraq
Hameed M. J. Al-Dulaimi
College of Biotechnology, Al-Nahrain University, Baghdad, Iraq

Abstract


The prevalence of overweight and obesity is rising worldwide, particularly, among women of reproductive age. Obesity during pregnancy can result in adverse outcomes for both mothers and fetuses. The current study was carried out to investigate whether the leptin (LEP), leptin receptor (LEPR) and insulin have a role in obesity development among Iraqi pregnant women. A case-control study included 90 pregnant women recruited at term for a scheduled cesarean delivery and classified equally according to body mass index (BMI) into three groups; control, overweight, and obese. Insulin, LEP, and LEPR were measured by enzyme-linked immunosorbent assay (ELISA). Obese group showed a significant increase in serum LEP (P<0.001), LEPR (p<0.05) and fasting insulin (P<0.05) concentrations compared with control group. Meanwhile, overweight females showed a significant (P<0.05) increase only in serum LEP and LEP/LEPR ratio (P<0.001,) compared to control group. Furthermore, maternal BMI was positively associated with, LEPR (adjusted r = 0.276, β: 0.104, P<0.01), LEP (adjusted r = 0.471, β: 0.256, P<0.001), and insulin (adjusted r = 0.439, β: 0.363, P<0.001) among entire data set. Similarly, BMI was positively associated with LEP (adjusted r = 0.297, β: 0.161, P<0.05), LEPR (adjusted r=0.444, β: 0.133, P<0.001) and insulin (adjusted r = 0.432, β: 0.266, P<0.001) among overweight/obese females. In Conclusion both of LEP and insulin are the strongest predictor for maternal BMI after age adjustment, while among overweight/obese females, LEPR has greatest impact on maternal obesity and insulin comes in second place.

Keywords


Maternal Obesity, Body Mass Index, Leptin, Leptin Receptor, Insulin, Lipid Profile, Insulin Resistance.

References